The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 03, 2009

Filed:

May. 02, 2006
Applicants:

Rajinder Singh, Belmont, CA (US);

Dane Goff, Redwood City, CA (US);

Ihab S. Darwish, San Mateo, CA (US);

Rao S. S. Kolluri, Foster City, CA (US);

Henry LU, Foster City, CA (US);

Gary Park, Moss Beach, CA (US);

Inventors:

Rajinder Singh, Belmont, CA (US);

Dane Goff, Redwood City, CA (US);

Ihab S. Darwish, San Mateo, CA (US);

Rao S. S. Kolluri, Foster City, CA (US);

Henry Lu, Foster City, CA (US);

Gary Park, Moss Beach, CA (US);

Assignee:

Rigel Pharmaceuticals, Inc., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/80 (2006.01); A61K 31/42 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to prodrugs and compositions thereof useful for treating or preventing Hepatitis C virus (HCV) infections. In particular, the present invention relates to prodrugs of substituted diphenyl-, diheteroaryl- and mixed phenyl heteroaryl substituted five-membered heterocycle compounds, compositions comprising the compounds and the use of such compounds and compositions to inhibit HCV replication and/or proliferation as a therapeutic approach towards the treatment and/or prevention of HCV infections in humans and animals.


Find Patent Forward Citations

Loading…